TYK2 inhibitors and compositions and methods thereof
US12129250B2 · kind B2 · utility
0Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2023 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Sep 25, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel class of therapeutic agents that are safe and effective TYK2 inhibitors and pharmaceutical compositions of these compounds and methods of preparation and use thereof against various TYK2-mediated diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.